Checkmab S.r.l.

📍 Milan, Italy🗓 Founded 2018👥 7 employees💰 Last funded Mar 2018
Biotechnology Research🌐 checkmab.eu
Website LinkedIn
CheckmAb Srl is an innovative start-up biotech company focused on the development of novel monoclonal antibodies for cancer immunotherapy, with the aim to provide safer and more effective therapies for patients. At present, the company is focused on the development of monoclonal antibodies for cancer immunotherapy, specifically targeting tumor-infiltrating regulatory T lymphocytes. These antibodies are expected to unleash the immunological response only within the neoplastic lesion, thereby avoiding harmful systemic autoimmune reactions that are too often associated with current immuntoherapies.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Checkmab S.r.l.?
Checkmab S.r.l. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Checkmab S.r.l. last raise funding?
The most recent investment in Checkmab S.r.l. recorded on gritt.io was in March 2018.
When was Checkmab S.r.l. founded?
Checkmab S.r.l. was founded in 2018.
What industry is Checkmab S.r.l. in?
Checkmab S.r.l. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Checkmab S.r.l. based?
Checkmab S.r.l. is headquartered in Milan, Italy.